Search results
Novo, Lilly Slip as Biden Demands GLP-1 Drug Price Cuts
Bloomberg· 2 days agoNovo Nordisk A/S and Eli Lilly & Co. shares fell early Tuesday after US President Joe Biden demanded...
5 things to know for July 3: Presidential race, Hurricane Beryl, India crowd crush, Alzheimer’s...
CNN.com· 1 day agoGrills won’t be the only thing sizzling this Fourth of July. Temperatures are set to climb to triple...
InnovationRx: A Fourth Dairy Worker Has Contracted Avian Flu
Forbes· 2 days agoInnovationRx is your weekly digest of healthcare news. Today, the Colorado Department of Public...
Fake Ozempic and Wegovy are flooding the market. Here are 4 steps to avoid dangerous counterfeit...
Fortune via Yahoo Finance UK· 7 days agoAlongside the warning, drug makers Eli Lily and Novo Nordisk have filed lawsuits against several...
Forbes Daily: ‘No Quick Rebound’ For Nike Amid Athletic Wear Decline
Forbes· 4 days agoBarbecue sauce is sure to be a staple at Fourth of July celebrations this week, and there’s a new...
Factbox-Stocks to watch as Biden and Trump vie for presidency
Reuters via Yahoo Finance UK· 1 day agoPHARMACEUTICALS AND INSURERS UBS sees a lower risk of drug price cuts and an inclination towards...
This shabby election campaign is finally over
The New Statesman· 10 hours agoOne Tory insider mused to me this week that the result was decided months ago, that their impending failure could be explained by Boris Johnson and Liz...
US FDA warns website over unlawful sale of weight-loss drugs
Reuters· 2 days agoThe U.S. Food and Drug Administration said on Tuesday it had warned a website called ozempen.com...
20 Of The Funniest Tweets About Married Life (June 25 - July 1)
HuffPost Life via Yahoo News· 3 days agoTho (@mom_tho) July 1, 2024 I just told my husband I found a giant active wasp nest in our backyard...
5 things to know for July 3: Presidential race, Hurricane Beryl, India crowd crush, Alzheimer’s...
CNN via Yahoo News UK· 1 day agoAlzheimer’s treatment The FDA on Tuesday approved a new drug to slow the progression of early symptomatic Alzheimer’s disease. Donanemab, made by the pharmaceutical giant Eli